Is Krystal Biotech, Inc. (KRYS) a Buy, Sell, or Hold?
NASDAQ : KRYS
Krystal Biotech, Inc. — Analyst Ratings
$335.19 USD
$7.69 (2.35%)
- Volume
- 520.34K
- Average Volume
- 408.46K
- Market Capitalization
- $9.88B
- P/E Ratio
- 43.25
- Dividend Yield
- 0.00%
- Price Target
- $327.00
- Year High
- $382.54
- Year Low
- $130.50
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $9.46
Analyst Consensus Summary
Consensus Rating
Buy
17 Analysts
Rating Score
4/5
Recommendation Strength
Upside/Downside
2.5%
vs Current Price
Price Target
$327.00
Average TargetPrice Target Range
Lowest Target
$300.00
11.7% UPSIDE
Average Target
$327.00
Median Estimate
Highest Target
$474.00
-29.3% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 17
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 17 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Joseph Pantginis | $361 | $322.995 | 2026-06-16 09:01 AM | 11.8% |
| Chardan Capital | Geulah Livshits | $323 | $282.6544 | 2026-02-18 07:56 AM | 14.3% |
| Jefferies | Roger Song | $371 | $291.1 | 2026-02-17 01:26 PM | 27.4% |
| Guggenheim | Debjit Chattopadhyay | $224 | $188.33 | 2025-10-17 06:44 AM | 18.9% |
| Stifel Nicolaus | Dae Gon Ha | $220 | $185 | 2024-09-11 02:53 AM | 18.9% |